XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Cumulative Effect, Period of Adoption
Common Stock
Retained Earnings
Cumulative Effect, Period of Adoption
Retained Earnings
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption
Total
Balance, beginning of period (Accounting Standards Update 2020-06) at Dec. 31, 2020 $ (41,456)   $ 6,682     $ (34,774)  
Balance, beginning of period at Dec. 31, 2020   $ 1,327,592   $ 464,524 $ (51,620)   $ 1,740,496
Balance, beginning of period (in shares) at Dec. 31, 2020   150,341          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss       (61,538)     (61,538)
Foreign currency translation adjustments         (4,462)   (4,462)
Accretion of redeemable noncontrolling interests       1,404     1,404
Activity in company stock plans, net and other   $ (1,128)         (1,128)
Activity in company stock plans, net and other (in shares)   783          
Share-based compensation   $ 7,471         7,471
Balance, end of period at Dec. 31, 2021   $ 1,292,479   411,072 (56,082)   1,647,469
Balance, end of period (in shares) at Dec. 31, 2021   151,124          
Balance, beginning of period at Dec. 31, 2020             3,855
Increase (Decrease) in Redeemable Noncontrolling Interests [Roll Forward]              
Net loss             (146)
Foreign currency translation adjustments related to redeemable noncontrolling interests             50
Accretion of redeemable noncontrolling interests             (1,404)
Acquisition of redeemable noncontrolling interests             (2,355)
Net loss       (87,784)     (87,784)
Foreign currency translation adjustments         (49,237)   (49,237)
Activity in company stock plans, net and other   $ (991)         (991)
Activity in company stock plans, net and other (in shares)   811          
Share-based compensation   $ 7,252         7,252
Balance, end of period at Dec. 31, 2022   $ 1,298,740   323,288 (105,319)   1,516,709
Balance, end of period (in shares) at Dec. 31, 2022   151,935          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss       (10,838)     (10,838)
Foreign currency translation adjustments         22,304   22,304
Repurchase of convertible senior notes   $ (35,469)         (35,469)
Repurchase of convertible senior notes (in shares)   1,500          
Termination of capped calls   $ 14,225         14,225
Repurchases of common stock   $ (11,988)         (11,988)
Repurchases of common stock (in shares)   (1,584)          
Activity in company stock plans, net and other   $ (92)         (92)
Activity in company stock plans, net and other (in shares)   440          
Share-based compensation   $ 6,149         6,149
Balance, end of period at Dec. 31, 2023   $ 1,271,565   $ 312,450 $ (83,015)   $ 1,501,000
Balance, end of period (in shares) at Dec. 31, 2023   152,291